Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese Male Subjects

Wyeth

Status and phase: Completed; Phase 1

Conditions: Schizophrenia

Treatments: Drug: SCA-136

Study type: Interventional

Funder types: Industry

Identifiers

NCT00505973

3153A1-1114

Details and patient eligibility

About

This study is being conducted to assess the safety and tolerability of ascending multiple oral doses of SCA-136 administered to healthy Japanese male subjects.

Sex: Male

Ages: 20 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healty Japanese men willing to use a medically acceptable form of contraception.

Exclusion criteria

• Any significant disease
• Positive urine drug screen
• Increased liver function tests
• Use of prescription drugs.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Double Blind